Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation

Calvin Yu-Chian Chen1

  • 1China Medical University Beigang Hospital, Yunlin, Taiwan.

Insights

The BCL2-associated athanogene (BAG1) protein repairs the DJ-1 mutant, restoring its function and dimer formation. This discovery offers molecular insights into Parkinson

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Mutant DJ-1 (L166P) is associated with familial early-onset Parkinson's disease (PD).
  • The DJ-1 mutation disrupts protein structure and prevents functional dimer formation.
  • BCL2-associated athanogene (BAG1) shows potential in repairing DJ-1 mutants.

Purpose of the Study:

  • To elucidate the molecular mechanism of protein-protein interactions between BAG1 and DJ-1.
  • To understand how BAG1 restores the function of the DJ-1 mutant.

Main Methods:

  • Utilized molecular simulation techniques to study BAG1-DJ-1 interactions.
  • Analyzed changes in protein structure, hydrogen bonds, and dimer formation.

Main Results:

  • BAG1 interaction restored disrupted alpha helix structures and hydrogen bonds in DJ-1.
  • Key hydrogen bonds (His126-Pro184) crucial for dimer interface were reformed.
  • Functional DJ-1 dimer formation was restored, confirmed by root mean square deviation of 0.74 Å.

Conclusions:

  • BAG1 effectively repairs the DJ-1 mutant by restoring its structural integrity and dimerization.
  • This study provides critical molecular insights into the BAG1-DJ-1 repair mechanism.
  • Findings may contribute to the development of novel therapeutic strategies for Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...